NANOG Gene Holds Key to Reversing Aging in Stem Cells
Recent research from the University at Buffalo has revealed an intriguing finding that could represent a significant advancement in our understanding of the mysteries surrounding aging: the possibility that aging is a reversible process. Because of these discoveries, scientists now have more opportunities to investigate strategies for stopping the deterioration of cellular functions and regaining the ability of cells and tissues to regenerate. Chemical engineer Stelios Andreadis is at the forefront of this ground-breaking research; his work with the embryonic gene NANOG is providing light on how it can effectively reverse the signs of aging by reprogramming skeletal muscle cells and senescent (aged) adult stem cells.
Although the potential of NANOG in reversing aging has been recognized, the mechanisms behind its action have remained shrouded in mystery. Two recent studies from Andreadis’ lab aim to unravel this enigma. The first, published in Cell Reports, delves into how NANOG restores mitochondrial function in aging stem cells. The second, featured in Nature Communications, focuses on the gene’s role in reversing aging in skeletal muscle.
Restoring Mitochondrial Function in Aging Stem Cells:
The Cell Reports study zooms in on senescent mesenchymal stem cells – aging cells with a diminished ability to divide and grow. The researchers discovered compromised glycolysis and mitochondrial respiration within these cells, prompting them to rewire their metabolism to break down the amino acid glutamine. Unfortunately, this metabolic shift led to an accumulation of urea, further impairing mitochondrial function and accelerating the aging process. The breakthrough came when the team restrained an enzyme called Glutaminase 1, effectively restoring mitochondrial function and reducing cellular senescence in animal models.
Similar positive outcomes were observed in cells from patients with Hutchinson-Gilford progeria syndrome, a genetic disorder causing rapid aging in children.
Reversing Aging in Skeletal Muscle:
The Nature Communications study delves into the age-related metabolic changes in myoblasts – cells that constitute muscle tissue. These experiments revealed impaired glycolysis and insulin resistance in aged myoblasts, driven by the breakdown of methionine, an essential amino acid found in meat, fish, and dairy. This process resulted in the production of significant levels of ammonium, exacerbating cellular aging.
To counteract this, the researchers expressed NANOG, suppressing the production of methionine adenosyltransferase 2A – a key enzyme in the methionine pathway. This intervention led to decreased ammonium levels, restored insulin sensitivity, increased glucose uptake, and enhanced muscle regeneration post-injury.
Implications and Future Directions:
These groundbreaking studies not only advance our understanding of NANOG but also pave the way for potential drug development targeting age-related diseases. The reversal of cellular senescence by restoring metabolic pathways in aging stem cells brings hope for improved treatments that could alleviate the suffering of individuals worldwide grappling with age-related illnesses. As we unlock the secrets encoded in the NANOG gene, the prospect of developing medicines that mimic its effects brings us one step closer to realizing the age-old dream of reversing the aging process.
The NANOG gene, inspired by the mythical land of youth, holds the key to unlocking the mysteries of aging. With each study, we peel back layers of the aging process, revealing the intricate dance of cellular mechanisms orchestrated by NANOG. As science progresses, the promise of new drugs and treatments for age-related diseases becomes more tangible, offering hope for a future where the fountain of youth may not be an elusive myth but a reality within our grasp.
Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113:643-55; PMID:12787505; http://dx.doi.org/ 10.1016/S0092-8674(03)00392-1 [PubMed] [CrossRef] [Google Scholar]
Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113:631-42; PMID:12787504; http://dx.doi.org/ 10.1016/S0092-8674(03)00393-3 [PubMed] [CrossRef] [Google Scholar]
Theunissen TW, Silva JC. Switching on pluripotency: a perspective on the biological requirement of Nanog. Philos Trans R Soc Lond B Biol Sci 2011; 366:2222-29; PMID:21727127; http://dx.doi.org/ 10.1098/rstb.2011.0003 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Gauchat D, Mazet F, Berney C, Schummer M, Kreger S, Pawlowski J, Galliot B. Evolution of Antp-class genes and differential expression of Hydra Hox/paraHox genes in anterior patterning. Proc Natl Acad Sci U S A 2000; 97:4493-8; PMID:10781050; http://dx.doi.org/ 10.1073/pnas.97.9.4493 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Booth HA, Holland PW. Eleven daughters of Nanog. Genomics 2004; 84:229-38; PMID:15233988; http://dx.doi.org/ 10.1016/j.ygeno.2004.02.014 [PubMed] [CrossRef] [Google Scholar]